Anti-Catenin, beta Antibody Clone 5H10
Additionally, this antibody has been validated by MS–QAVA™.
Search Results for: ms-qava
Anti-Cytokeratin 8/18 Antibody Clone KRT8.18/1346
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone CIP1/823
.jpg)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-MCM7 Antibody Clone MCM7/1468
![Analysis of Mass Spec data (dashed-line) of fractions stained with MCM7 MS-QAVA™ monoclonal antibody [Clone: MCM7/1468] (solid-line), reveals that less than 3.8% of signal is attributable to non-specific binding of anti-MCM7 [Clone: MCM7/1468] to targets other than MCM7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-4176-MSM3-P0-anti-MCM7-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Bax Antibody Clone 2D2
.jpg)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-CD44 / HCAM Antibody Clone HCAM/918
![Analysis of Mass Spec data (dashed-line) of fractions stained with CD44 / HCAM MS-QAVA™ monoclonal antibody [Clone: HCAM/918] (solid-line), reveals that less than 12.6% of signal is attributable to non-specific binding of anti-CD44 / HCAM Std. Anti-Human, Primate [Clone HCAM/918] to targets other than CD44 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-960-MSM2-P1-anti-CD44-HCAM-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 7 Antibody Clone KRT7/1499R
![Analysis of Mass Spec data (dashed-line) of fractions stained with Cytokeratin 7 MS-QAVA™ monoclonal antibody [Clone: KRT7/1499R] (solid-line), reveals that less than 13.6% of signal is attributable to non-specific binding of anti-Cytokeratin 7 [Clone KRT7/1499R] to targets other than KRT7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-3855-RBM9-P0-anti-Cytokeratin-7-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-ZAP70 Antibody Clone 2F3.2
![Staining with mouse monoclonal ZAP70 [Clone 2F3.2] antibody in formalin-fixed paraffin-embedded human tonsil.](https://enquirebio.com/wp-content/uploads/2019/01/ZAP70 IHC human Tonsil (2F3.2).jpg)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12 + DO-7
![Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12 + DO-7] (solid-line), reveals that less than 10.8% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12 + DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7157-MSM3-P1-anti-p53-Tumor-Suppressor-Protein-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-SUMO-1 Antibody Clone SUMO1/1188
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Vimentin Antibody Clone VM1170
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone DCS-60.2
.jpg)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-CD3e Antibody Clone C3e/1308
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Catenin, beta Antibody Clone 6F9
![Analysis of Mass Spec data (dashed-line) of fractions stained with Catenin, beta MS-QAVA™ monoclonal antibody [Clone: 6F9] (solid-line), reveals that less than 5.2% of signal is attributable to non-specific binding of anti-Catenin, beta [Clone: 6F9] to targets other than CTNNB1 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-1499-MSM5-P0-anti-Catenin-beta-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-EpCAM / CD326 Antibody Clone EGP40/1372
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 7 Antibody Clone OV-TL12/30
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cdk1 / p34cdc2 Antibody Clone CDK1/873
![Analysis of Mass Spec data (dashed-line) of fractions stained with Cdk1 / p34cdc2 MS-QAVA™ monoclonal antibody [Clone: CDK1/873] (solid-line), reveals that less than 1.4% of signal is attributable to non-specific binding of anti-Cdk1 / p34cdc2 [Clone CDK1/873] to targets other than CDC2 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-983-MSM2-P1-anti-Cdk1-p34cdc2-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone WA-1
.jpg)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 8/18 Antibody Clone C-43 + DC10
Additionally, this antibody has been validated by MS–QAVA™.